TACLAMINE HYDROCHLORIDE

Details

Stereochemistry	RACEMIC
Molecular Formula	C21H23N.ClH
Molecular Weight	325.875
Optical Activity	( + / - )
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.C1CCN2C[C@H]3C4=CC=CC=C4CCC5=C3C(=CC=C5)[C@@H]2C1

InChI

InChIKey=LOSFVNFVCCXCEN-FKLPMGAJSA-N

InChI=1S/C21H23N.ClH/c1-2-8-17-15(6-1)11-12-16-7-5-9-18-20-10-3-4-13-22(20)14-19(17)21(16)18;/h1-2,5-9,19-20H,3-4,10-14H2;1H/t19-,20-;/m0./s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1156020 | https://www.ncbi.nlm.nih.gov/pubmed/6140017

Taclamine is an isoquinoline derivative patented by Ayerst, McKenna and Harrison Ltd. as central nervous system depressant and anti-inflammatory agent. In preclinical models, Taclamine antagonizes the turnover of noradrenaline and dopamine in the rat brain during immobilization stress without effects on brain serotonin turnover

Originator

Approval Year

PubMed

Title	Date	PubMed
Effects of taclamine (AY-22,214), a new psychoactive agent, on catecholamine and serotonin metabolism.	1975-01	1156020

Patents

Name

Type

Language

TACLAMINE HYDROCHLORIDE

Official Name

English

AY-22,214

Preferred Name

English

AY-22214

Code

English

TACLAMINE HYDROCHLORIDE [USAN]

Common Name

English

1H-BENZO(6,7)CYCLOHEPTA(1,2,3-DE)PYRIDO(2,1-A)ISOQUINOLINE, 2,3,4,4A,8,9,13B,14-OCTAHYDRO-, HYDROCHLORIDE

Common Name

English

TACLAMINE HYDROCHLORIDE, (4AS-TRANS)-ISOMER (±)-

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C78272